Literature DB >> 2174596

Fowlpox virus recombinant encoding the measles virus fusion protein: protection of mice against fatal measles encephalitis.

F Wild1, P Giraudon, D Spehner, R Drillien, J P Lecocq.   

Abstract

A recombinant Fowlpox virus engineered to encode the measles virus fusion protein was shown to protect mice against a challenge measles infection. A vaccine dose of about 10(6) p.f.u. was needed to protect nearly 100% of the animals. Mice failed to develop a significant level of antibodies directed against measles virus suggesting that other components of the immune system may be involved.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2174596     DOI： 10.1016/0264-410x(90)90243-f

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  10 in total

1.  Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.

Authors:  A P Durbin; M H Skiadopoulos; J M McAuliffe; J M Riggs; S R Surman; P L Collins; B R Murphy
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys.

Authors:  M H Skiadopoulos; S R Surman; J M Riggs; P L Collins; B R Murphy
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  Recombinant adenovirus expressing the haemagglutinin of Peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR.

Authors:  Rebecca Herbert; Jana Baron; Carrie Batten; Michael Baron; Geraldine Taylor
Journal:  Vet Res       Date:  2014-02-26       Impact factor: 3.683

4.  Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein.

Authors:  R S van Binnendijk; J P Versteeg-van Oosten; M C Poelen; H F Brugghe; P Hoogerhout; A D Osterhaus; F G Uytdehaag
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

5.  Fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus induce neutralizing antibodies and reduce viremia in chickens.

Authors:  J G Calvert; K Nazerian; R L Witter; N Yanagida
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.

Authors:  M Wang; V Bronte; P W Chen; L Gritz; D Panicali; S A Rosenberg; N P Restifo
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

7.  Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections.

Authors:  G Berhe; C Minet; C Le Goff; T Barrett; A Ngangnou; C Grillet; G Libeau; M Fleming; D N Black; A Diallo
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

8.  Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge.

Authors:  J Taylor; S Pincus; J Tartaglia; C Richardson; G Alkhatib; D Briedis; M Appel; E Norton; E Paoletti
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

Review 9.  The evolution of poxvirus vaccines.

Authors:  Lucas Sánchez-Sampedro; Beatriz Perdiguero; Ernesto Mejías-Pérez; Juan García-Arriaza; Mauro Di Pilato; Mariano Esteban
Journal:  Viruses       Date:  2015-04-07       Impact factor: 5.048

Review 10.  Recombinant fowlpox virus vaccines for poultry.

Authors:  D B Boyle; H G Heine
Journal:  Immunol Cell Biol       Date:  1993-10       Impact factor: 5.126
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.